For the quarter ending 2025-09-30, LUNG made $21,502K in revenue. -$14,355K in net income. Net profit margin of -66.76%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 21,502 | 23,859 | 22,538 | 21,310 |
| Cost of goods sold | 5,450 | 6,655 | 6,196 | 5,476 |
| Gross profit | 16,052 | 17,204 | 16,342 | 15,834 |
| Research and development | 4,846 | 5,306 | 4,756 | 4,106 |
| Selling, general and administrative | 25,599 | 26,702 | 26,149 | 25,705 |
| Total operating expenses | 30,445 | 32,008 | 30,905 | 29,811 |
| Loss from operations | -14,393 | -14,804 | -14,563 | -13,976 |
| Interest income | 611 | 723 | 864 | 1,243 |
| Interest expense | 805 | 799 | 781 | 863 |
| Other income (expense), net | 758 | -116 | 167 | 246 |
| Net loss before tax | -13,829 | -14,996 | -14,313 | -13,350 |
| Income tax expense | 128 | 177 | 135 | 112 |
| Net loss | -13,957 | -15,173 | -14,448 | -13,462 |
| Currency translation adjustment | -399 | 435 | 111 | -459 |
| Change in unrealized gains (losses) on marketable securities | 1 | -1 | -22 | -90 |
| Total other comprehensive (loss) income | -398 | 434 | 89 | -549 |
| Comprehensive loss | -14,355 | -14,739 | -14,359 | -14,011 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.34 | -0.38 | -0.36 | -0.345 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.34 | -0.38 | -0.36 | -0.345 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 40,936,896 | 40,429,655 | 39,954,658 | -19,554,220 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 40,936,896 | 40,429,655 | 39,954,658 | -19,554,220 |
Pulmonx Corp (LUNG)
Pulmonx Corp (LUNG)